In vitro and ex vivo antimycobacterial potential of azole drugs against Mycobacterium tuberculosis H37Rv

FEMS Microbiology Letters

Volumn 251, Issue 1, 2005, Pages 19-22

  Ahmad, Zahoor ^a   Sharma, Sadhna ^a   Khuller, G K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Antitubercular drugs; Clotrimazole; Econazole; Mycobacteria

Indexed keywords

CLOTRIMAZOLE; ECONAZOLE; ISONIAZID; PYRROLE DERIVATIVE; RIFAMPICIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; FEMALE; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; CLOTRIMAZOLE; COLONY COUNT, MICROBIAL; DRUG SYNERGISM; ECONAZOLE; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN;

CORYNEBACTERINEAE; MYCOBACTERIUM TUBERCULOSIS;

EID: 24944503971     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.femsle.2005.07.022     Document Type: Article

References (10)

1. H.M. Guardiola-Diaz, L.A. Foster, D. Mushrush, and A.D.N. Vaz Azole-antifungal binding to a novel cytochrome P450 from Mycobacterium tuberculosis Biochemical Pharmacology 61 2001 1463 1470
2. K.J. McLean, K.R. Marshall, A. Richmond, I.S. Hunter, K. Fowler, T. Kieser, S.S. Gurcha, G.S. Besra, and A.W. Munro Azole antifungals are potent inhibitors of cytochrome P450 mono-oxygenases and bacterial growth in mycobacteria and streptomycetes Microbiology 148 2002 2937 2949
3. P.G. Hartman Inhibitors of ergosterol biosynthesis as antifungal agents Current Pharmaceutical Design 3 1997 177 208
4. J. Colin, D.C. Jackson, Lamb, D.E. Kelly, and S.L. Kelly Bactericidal and inhibitory effects of azole antifungal compounds on Mycobacterium smegmatis FEMS Microbiol. Lett. 192 2000 159 162
5. A. Kalita, I. Verma, and G.K. Khuller Role of human Neutrophil peptide-1 as a possible adjunct to antituberculosis chemotherapy J. Infec. Dis. 190 2004 1476 1480
6. D.J. Turner, S.L. Hoyle, V.A. Snewin, G. Marie-Pierre, I.N. Brown, and D.B. Young An ex vivo culture model for screening drug activity against in vivo phenotypes of Mycobacterium tuberculosis Microbiology 148 2002 2929 2936
7. J.H. Michael, and H.C. Michael Design and synthesis of antitubercular: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff base J. Antimicrob. Chemother. 53 2004 185 191
8. J.C. Betts, P.T. Lukey, and L.C. Robb Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling Mol. Microbiol. 43 2002 717 731
9. B.H. Leonid, D.I. Michael, and J.L. Pamela Combinations of rifampin or rifabutin plus ethambutol against Mycobacterium avium complex Am. Rev. Resp. Dis. 137 1998 711 715
10. F. Benko, A. Hernádi, A. Megyeri, G. Kiss, Z. Somogyi, F. Tegyey, Kraicsovits, and P. Kovács Comparison of the toxicity of fluconazole and other azole antifungal drugs to murine and human granulocytes-macrophage progenitor cells in vitro J. Antimicrob. Chemother. 43 1999 675 681